Changes

== Contemporary approach: ==

== Contemporary approach: ==

<div style='text-align:justify;'>'''Pharmacovigilence in Ayurveda:'''<br/>Considering the global aclaimation of ayurveda aushadha, the need of pharmacovigilence in Ayurveda seems imperative. A common myth exists in the society that herbal medicines do not have any side effects. This leads to large scale consumption of Ayurveda aushadha without consultation of Ayurved practitioner and its ill effects are often observed. Adverse drug reactions are sometimes reported in ayurveda which may be due to administration of unwholesome drugs or drug overdose. Drug to drug interaction may occur, if aushadha combinations without the consultation of authorised ayurveda practitioner is consumed. Contamination, adulteration or poor quality drugs may compromise the safety of patients. Based on WHO guidelines, regarding the safety of herbal drugs, Department of AYUSH, Ministry of Health and Family Welfare, Govermment of India established National Pharmacovigilence Programme for Ayurveda, Siddha and Unani drugs in 2008-09 at Institute of Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, India.</br>The Ministry of AYUSH has introduced new Central Sector scheme for promoting pharmaovigilence in Ayurveda, Siddha, Unani and Homeopathy drugs. Prime objective of the scheme is to develop the culture of documenting adverse effects and undertake safety monitoring in Ayurveda, Siddha and Unani drugs and surveillance of misleading advertisements appearing in the print and electronic media. All India Institute of Ayurveda, New Delhi has been designated as National Pharmacovigilance Centre.</div>

<div style='text-align:justify;'>'''Pharmacovigilence in [[Ayurveda|Ayurveda]]:'''<br/>Considering the global aclaimation of [[Ayurveda|ayurveda]] aushadha, the need of pharmacovigilence in [[Ayurveda|Ayurveda]] seems imperative. A common myth exists in the society that herbal medicines do not have any side effects. This leads to large scale consumption of [[Ayurveda|Ayurveda]] aushadha without consultation of Ayurved practitioner and its ill effects are often observed. Adverse drug reactions are sometimes reported in [[Ayurveda|ayurveda]] which may be due to administration of unwholesome drugs or drug overdose. Drug to drug interaction may occur, if aushadha combinations without the consultation of authorised [[Ayurveda|ayurveda]] practitioner is consumed. Contamination, adulteration or poor quality drugs may compromise the safety of patients. Based on WHO guidelines, regarding the safety of herbal drugs, Department of AYUSH, Ministry of Health and Family Welfare, Govermment of India established National Pharmacovigilence Programme for [[Ayurveda|Ayurveda]], Siddha and Unani drugs in 2008-09 at Institute of Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, India.</br>The Ministry of AYUSH has introduced new Central Sector scheme for promoting pharmaovigilence in Ayurveda, Siddha, Unani and Homeopathy drugs. Prime objective of the scheme is to develop the culture of documenting adverse effects and undertake safety monitoring in [[Ayurveda|Ayurveda]], Siddha and Unani drugs and surveillance of misleading advertisements appearing in the print and electronic media. All India Institute of Ayurveda, New Delhi has been designated as National Pharmacovigilance Centre.</div>

<big>'''[[Special:ContactMe|Send us your suggestions and feedback on this page.]]'''</big>

<big>'''[[Special:ContactMe|Send us your suggestions and feedback on this page.]]'''</big>